540 Substance-Related and Addictive Disorders
years); association with others known to use inhalants; membership in certain small com-
munities with prevalent inhalant use (e.g., so me native or aborigin al communities, home-
less street children and adoles cents); or unusual access to certain inhalant substances.
Other inhalant-related disorders. Episodes of inhalant intoxication do occur during,
but are not identical with, other inhalant-related  disorders. Those inha lant-related disorders
are recognized by their respective diagnostic  criteria: inhalant use disorder, inhalant-
induced neurocognitive disorder, inhalant-i nduced psychotic disorder, inhalant-induced
depressive disorder, inhalant-induced anxiet y disorder, and other inhalant-induced dis-
orders.
Other toxic, metabolic, traumatic, neoplastic, or infectious disorders that impair brain
function and cognition. Numerous neurological and other medical conditions may pro-
duce the clinically significant behavioral or  psychological changes (e.g., belligerence, as-
saultiveness, apathy, impaired judgment) that also characterize inhalant intoxication. 
Other Inhalant-Induced Disorders
The following inhalant-induced  disorders are described in other chapters of the manual
with disorders with which they share ph enomenology (see the substance/medication-
induced mental disorders in these chapters): inhalant-induced psychotic disorder (“Schizo-
phrenia Spectrum and Other Psychotic Disord ers”); inhalant-induced depressive disorder
(“Depressive Disorders”); inhalant-induced an xiety disorder (“Anxiet y Disorders”); and in-
halant-induced major or mild neurocognitive disorder (“Neur ocognitive Disorders”). For
inhalant intoxication delirium, see the criteria and discussion of de lirium in the chapter